RSS-Feed abonnieren
DOI: 10.1055/s-2005-872075
Synthesis of 24,24-Ethanovitamin D3 Lactones Using Ruthenium-Catalyzed Intermolecular Enyne Metathesis: Potent Vitamin D Receptor Antagonists
Publikationsverlauf
Publikationsdatum:
20. Juli 2005 (online)
![](https://www.thieme-connect.de/media/synthesis/200515/lookinside/thumbnails/10.1055-s-2005-872075-1.jpg)
Abstract
Novel vitamin D receptor antagonists, 24,24-ethanovitamin D3-26,23-lactones 6 and 7 and their 2α-functionalized analogues 6a-c and 7a-c were synthesized and their biological activities were evaluated. The triene structure of vitamin D3 was constructed using Pd-catalyzed alkenylative cyclization of A-ring precursor enynes 12 and 12a-c with the CD-ring bromo-olefin counterpart having 24,24-ethano-α-methylene-γ-lactone on the side chain (21 or 22). The CD-ring precursors 21 and 22 were efficiently synthesized via Ru-catalyzed intermolecular enyne metathesis of 15 with ethylene to give dienone 17 followed by cyclopropanation. The VDR antagonistic activity of the newly designed vitamin D3 lactones 6 and 7 increased to 2.8 times that of TEI-9647 (2) in a HL-60 cell differentiation evaluating system. Moreover, introduction of three substituents, that is, a methyl (6a and 7a), a 3-hydroxypropyl (6b and 7b), or a 3-hydroxypropoxyl group (6c and 7c) into the C2α position of 6 and 7, resulted in marked enhancement, up to 19 times, of the antagonistic activity toward VDR.
Key words
vitamins - antagonist - lactones - ruthenium - metathesis - enynes
-
1a
Vitamin D
Feldman D.Glorieux FH.Pike JW. Academic Press; New York: 1997. -
1b
Ettinger RA.DeLuca HF. Adv. Drug Res. 1996, 28: 269 - 2
Bouillon R.Okamura WH.Norman AW. Endocr. Rev. 1995, 16: 200 -
3a
Evans RM. Science 1988, 240: 889 -
3b
Umezono K.Murakami KK.Thompson CC.Evans RM. Cell 1991, 65: 1255 - 4
Takeyama K.Masuhiro Y.Fuse H.Endoh H.Murayama A.Kitanaka S.Suzawa M.Yanagisawa J.Kato S. Mol. Cell Biol. 1999, 19: 1049 -
5a
Konno K.Maki S.Fujishima T.Liu Z.Miura D.Chokki M.Takayama H. Bioorg. Med. Chem. Lett. 1998, 8: 151 -
5b
Konno K.Fujishima T.Maki S.Liu Z.Miura D.Chokki M.Ishizuka S.Yamaguchi K.Kan Y.Kurihara M.Miyata N.Smith C.DeLuca HF.Takayama H. J. Med. Chem. 2000, 43: 4247 -
6a
Suhara Y.Nihei K.Tanigawa H.Fujishima T.Konno K.Nakagawa K.Okano T.Takayama H. Bioorg. Med. Chem. Lett. 2000, 10: 1129 -
6b
Suhara Y.Nihei K.Kurihara M.Kittaka A.Yamaguchi K.Fujishima T.Konno K.Miyata N.Takayama H. J. Org. Chem. 2001, 66: 8760 -
7a
Kittaka A.Suhara Y.Takayanagi H.Fujishima T.Kurihara M.Takayama H. Org. Lett. 2000, 2: 2619 -
7b
Saito N.Suhara Y.Kurihara M.Fujishima T.Honzawa S.Takayanagi H.Kozono T.Matsumoto M.Ohmori M.Miyata N.Takayama H.Kittaka A. J. Org. Chem. 2004, 69: 7463 - 8 For our account, see:
Takayama H.Kittaka A.Fujishima T.Suhara Y. Vitamin D Analogs in Cancer Prevention and Therapy, Recent Results in Cancer Research Vol. 164:Reichrath J.Friedrich M.Tilgen W. Springer-Verlag; Berlin: 2003. p.289 - This concept was also good for 1α,25-dihydroxy-19-norvitamin D3, see:
-
9a
Ono K.Yoshida A.Saito N.Fujishima T.Honzawa S.Suhara Y.Kishimoto S.Sugiura T.Waku K.Takayama H.Kittaka A. J. Org. Chem. 2003, 68: 7407 -
9b
Yoshida A.Ono K.Suhara Y.Saito N.Takayama H.Kittaka A. Synlett 2003, 1175 -
10a
Miura D.Manabe K.Ozono K.Saito M.Gao Q.Norman AW.Ishizuka S. J. Biol. Chem. 1999, 274: 16392 -
10b
Ozono K.Saito M.Miura D.Michigami T.Nakajima S.Ishizuka S. J. Biol. Chem. 1999, 274: 32376 -
10c
Miura D.Manabe K.Gao Q.Norman AW.Ishizuka S. FEBS Lett. 1999, 460: 297 -
10d
Ishizuka S.Miura D.Eguchi H.Ozono K.Chokki M.Kamimura T.Norman AW. Arch. Biochem. Biophys. 2000, 380: 92 -
10e
Ishizuka S.Miura D.Ozono K.Chokki M.Mimura H.Norman AW. Endocrinol. 2001, 142: 59 -
10f
Ishizuka S.Miura D.Ozono K.Saito M.Eguchi H.Chokki M.Norman AW. Steroids 2001, 66: 227 - 11 For a recent report on the other type of VDR antagonist of 25-carboxylic esters ZK159222 and ZK168281, see:
Väisänen S.Peräkylä M.Kärkkäinen JI.Steinmeyer A.Carlberg C. J. Mol. Biol. 2002, 315: 229 -
12a
Ishizuka S.Ishimoto S.Norman AW. Biochemistry 1984, 23: 1473 -
12b
Ishizuka S.Ohba T.Norman AW. Vitamin D: Molecular, Cellular and Chemical EndocrinologyNorman AW.Schaefer K.Grigoleit HG.von Herrath D. Walter de Gruyter; Berlin: 1988. p.143 -
13a
Carlberg C. J. Cell. Biochem. 2003, 88: 274 -
13b
Toell A.Gonzalez MM.Ruf D.Steinmeyer A.Ishizuka S.Carlberg C. Mol. Pharmacol. 2001, 59: 1478 -
14a
Saito N.Matsunaga T.Fujishima T.Anzai M.Saito H.Takenouchi K.Miura D.Ishizuka S.Takayama H.Kittaka A. Org. Biomol. Chem. 2003, 1: 4396 -
14b
Saito N.Saito H.Anzai M.Yoshida A.Fujishima T.Takenouchi K.Miura D.Ishizuka S.Takayama H.Kittaka A. Org. Lett. 2003, 5: 4859 -
14c
Saito N.Masuda M.Matsunaga T.Saito H.Anzai M.Takenouchi K.Miura D.Ishizuka S.Takimoto-Kamimura M.Kittaka A. Tetrahedron 2004, 60: 7951 - 15
Wiggins LS. Methods Carbohydr. Chem. 1963, 2: 181 - 16
Taillefumier C.Chapleur Y. Can. J. Chem. 2000, 78: 708 - 17 Previously, the enyne 12 was prepared through Sharpless asymmetric dihydroxylation of 3-butenyl 4-methoxyphenyl ether:
Fujishima T.Konno K.Nakagawa K.Kurobe M.Okano T.Takayama H. Bioorg. Med. Chem. 2000, 8: 123 - 18 The original works of Ru-catalyzed intermolecular enyne metathesis, see:
Kinoshita A.Sakakibara N.Mori M. J. Am. Chem. Soc. 1997, 119: 12388 -
19a
Scholl M.Ding S.Lee CW.Grubbs RH. Org. Lett. 1999, 1: 953 -
19b
Garber SB.Kingsbury JS.Gray BL.Hoveyda AH. J. Am. Chem. Soc. 2000, 122: 8168 -
19c
Wakamatsu H.Blechert S. Angew. Chem. Int. Ed. 2002, 41: 2403 -
19d
instability of 15 and 16d at r.t. would cause low yield of 17 and low recovery of 15.
- 21
Trost BM.Dumas J.Villa M. J. Am. Chem. Soc. 1992, 114: 9836 -
22a
Eisman JA.Hamstra AJ.Kream BE.DeLuca HF. Arch. Biochem. Biophys. 1976, 176: 235 -
22b
Inaba M.DeLuca HF. Biochim. Biophys. Acta 1989, 1010: 20 - 23
Collins SJ.Ruscetti FW.Gallagher RE.Gallo RC. J. Exp. Med. 1979, 149: 969 -
24a
Suhara Y.Kittaka A.Kishimoto S.Calverly MJ.Fujishima T.Saito N.Sugiura T.Waku K.Takayama H. Bioorg. Med. Chem. Lett. 2002, 12: 3255 -
24b
Honzawa S.Yamamoto Y.Hirasaka K.Takayama H.Kittaka A. Heterocycles 2003, 61: 327 -
24c
Honzawa S.Suhara Y.Nihei K.Saito N.Kishimoto S.Fujishima T.Kurihara M.Sugiura T.Waku K.Takayama H.Kittaka A. Bioorg. Med. Chem. Lett. 2003, 13: 3503 - 25 For an excellent description of the VDR-generated transactivation mechanism, see:
Masuno H.Yamamoto K.Wang X.Choi M.Ooizumi H.Shinki T.Yamada S. J. Med. Chem. 2002, 45: 1825 - Recent reviews on the function of VDR in response to 1 and other synthetic ligands, see:
-
26a
Carlberg C. In Vitamin D Analogs in Cancer Prevention and Therapy, Recent Results in Cancer Research Vol. 164: Reichrath J., Friedrich M., Tilgen M., Eds., Springer; Berlin: 2003. p.29 -
26b
Carlberg C. J. Steroid Biochem. Mol. Biol. 2004, 89-90: 227 ; see also ref. 13 - 27
Bula CM.Bishiop JE.Ishizuka S.Norman AW. Mol. Endocrinol. 2000, 14: 1788 -
28a
Ochiai E.Miura D.Eguchi H.Takenouchi K.Harada Y.Azuma Y.Kamimura T.Ishizuka S. J. Bone. Miner. Res. 2003, 18 (suppl. 2): S103 -
28b
Ochiai E.Miura D.Eguchi H.Ohara S.Takenouchi K.Harada Y.Azuma Y.Kamimura T.Norman AW.Ishizuka S. Mol. Endocrinol. 2005, 19: 1147 - 29
Peräkylä M.Molnár F.Carlberg C. Chem. Biol. 2004, 11: 1147 - 30
Takenouchi K.Sogawa R.Manabe K.Saitoh H.Gao Q.Miura D.Ishizuka S. J. Steroid Biochem. Mol. Biol. 2004, 89-90: 31 - 31 It is well known that some biologically active natural products having an α-methylene-γ-lactone structure react with the thiol group of cysteine to give the corresponding cysteine adduct:
Kupchan SM.Fessler DC.Eakin MA.Giacobbe TJ. Science 1970, 168: 376 - For recent reviews on Paget"s bone disease, see:
-
32a
Reddy SV. J. Cell Biochem. 2004, 93: 688 -
32b
Roodman GD.Windle JJ. J. Clin. Invest. 2005, 115: 200 - 33
Wender PA.Sieburth S.Petraitis JJ.Singh SK. Tetrahedron 1981, 37: 1967
References
Crystal data of 20 are as follows: C21H34BrO2, space group P212121, Z = 4, a = 7.785 (6), b = 9.445 (9), c = 27.35 (2) Å, V = 2010 (2) Å3, Dcalcd = 1.313 g/cm3, R1 = 0.063 for 16610 reflections [I > 3.00s (I)], wR2 = 0.068 [I > 3.00s (I)]; structure solution and refinement were performed using Direct Methods (SIR92) and full-matrix least-squares on F, respectively. Diffractometer Rigaku RAXIS-RAPID, graphite monochlomated CuKα (λ = 1.54187 Å).